EQ Wealth Advisors’s AbbVie ABBV Stock Holding History

EQ Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$283K	Hold	1,300	–	–	0.17%	47
2025 Q4	$297K	Hold	1,300	–	–	0.18%	45
2025 Q3	$301K	Hold	1,300	–	–	0.2%	42
2025 Q2	$241K	Hold	1,300	–	–	0.16%	41
2025 Q1	$272K	Hold	1,300	–	–	0.22%	42
2024 Q4	$231K	Buy	+1,300	New	+$239K	0.22%	44

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EQ Wealth Advisors's ABBV Position: Q1 2026 in Review

EQ Wealth Advisors held its AbbVie (ABBV) position steady in Q1 2026 at 1,300 shares worth $283K. The position accounts for 0.17% of the portfolio, ranked #47.

EQ Wealth Advisors first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $301K in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

EQ Wealth Advisors held 1,300 shares of AbbVie worth $283K as of Q1 2026.
EQ Wealth Advisors left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 0.17% of EQ Wealth Advisors's portfolio in Q1 2026, its #47 holding.
EQ Wealth Advisors first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
EQ Wealth Advisors's AbbVie position peaked at $301K in Q3 2025.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on EQ Wealth Advisors's 13F filing for Q1 2026, filed 1 May 2026.